Truist Financial Corp boosted its stake in Globe Life Inc. (NYSE:GL – Free Report) by 18.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 33,474 shares of the company’s stock after acquiring an additional 5,133 shares during the period. Truist Financial Corp’s holdings in Globe Life were worth $4,682,000 at the end of the most recent quarter.
Other institutional investors have also added to or reduced their stakes in the company. CYBER HORNET ETFs LLC bought a new stake in Globe Life in the second quarter valued at approximately $28,000. MUFG Securities EMEA plc bought a new stake in Globe Life in the second quarter valued at approximately $31,000. Quent Capital LLC bought a new stake in Globe Life in the third quarter valued at approximately $36,000. Torren Management LLC bought a new stake in Globe Life in the fourth quarter valued at approximately $37,000. Finally, Root Financial Partners LLC bought a new stake in Globe Life in the third quarter valued at approximately $44,000. 81.61% of the stock is currently owned by institutional investors.
Globe Life Price Performance
Globe Life stock opened at $151.21 on Monday. The stock has a market capitalization of $11.74 billion, a price-to-earnings ratio of 10.46 and a beta of 0.50. Globe Life Inc. has a 52-week low of $116.73 and a 52-week high of $156.69. The stock’s 50 day moving average price is $144.95 and its two-hundred day moving average price is $140.39. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.07 and a current ratio of 0.07.
Globe Life Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Monday, July 6th will be given a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Monday, July 6th. Globe Life’s dividend payout ratio is presently 9.13%.
Insider Activity at Globe Life
In other news, CEO James Matthew Darden sold 18,318 shares of the company’s stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $145.10, for a total transaction of $2,657,941.80. Following the transaction, the chief executive officer directly owned 51,093 shares of the company’s stock, valued at $7,413,594.30. This represents a 26.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Robert Edward Hensley sold 712 shares of the company’s stock in a transaction that occurred on Wednesday, February 25th. The stock was sold at an average price of $142.59, for a total value of $101,524.08. Following the transaction, the executive vice president directly owned 8,580 shares in the company, valued at $1,223,422.20. The trade was a 7.66% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 89,720 shares of company stock valued at $13,322,826 over the last three months. 2.11% of the stock is currently owned by company insiders.
Analyst Ratings Changes
A number of research firms have issued reports on GL. Texas Capital upgraded Globe Life to a “strong-buy” rating in a report on Wednesday, March 18th. Evercore set a $157.00 price target on Globe Life in a report on Wednesday, February 18th. JPMorgan Chase & Co. increased their price target on Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Weiss Ratings cut Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a report on Monday, April 27th. Finally, Piper Sandler upgraded Globe Life to a “strong-buy” rating in a report on Thursday, April 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $172.67.
Check Out Our Latest Report on GL
Globe Life Profile
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
See Also
- Five stocks we like better than Globe Life
- 3 Companies Quietly Essential to Data Center and AI Operations
- Beyond NVIDIA: Picks-and-Shovels AI Plays with Strong Momentum
- Quantum Earnings Season Is Ramping Up—What to Watch From 2 Major Players
- Flutter Sees Post-Earnings Boost as FanDuel Shows Signs of Recovery
Want to see what other hedge funds are holding GL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GL – Free Report).
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
